ClassID:

94470

C07D237/26 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems

Sub-classes:
Recent Application in this class:
#1
20260109686
2026-04-23

PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS

#2
20250161536
2025-05-22

CLICK-CROSSLINKED HYDROGELS AND METHODS OF USE

#3
20250115559
2025-04-10

PREPARATION METHOD OF PYRIDAZINONE DERIVATIVE, AND INTERMEDIATE THEREOF

#4
20250100976
2025-03-27

EXTERNAL STIMULUS-RESPONSIVE CLICK REACTION TECHNOLOGY

#5
20250024752
2025-01-16

PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND

#6
20240336574
2024-10-10

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#7
20240191002
2024-06-13

CROSS-LINKED POLYCARBOXYLATED POLYSACCHARIDES AND METHODS OF USE THEREOF

#8
20240091371
2024-03-21

BIO-ORTHOGONAL DRUG ACTIVATION

#9
20230139797
2023-05-04

Fluorescent detection of amines and hydrazines and assaying methods thereof

#10
20210261693
2021-08-26

Cross-linked polycarboxylated polysaccharides and methods of use thereof

#11
20210162060
2021-06-03

Bio-orthogonal drug activation

#12
20210128790
2021-05-06

Click-crosslinked hydrogels and methods of use

#13
20210032208
2021-02-04

Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern

#14
20200392063
2020-12-17

Labile esters of agrochemicals for controlled release and reduction of off-site movement

#15
20200190039
2020-06-18

Materials for organic electroluminescent devices

#16
20190345116
2019-11-14

Synthesis of tetracyclines and analogues thereof

#17
20190336612
2019-11-07

Bio-orthogonal drug activation

#18
20190225880
2019-07-25

Fluorescent detection of amines and hydrazines and assaying methods thereof

#19
20180319741
2018-11-08

Sulfonylaminobenzamide compounds as anthelmintics

#20
20180292396
2018-10-11

Method for measuring tyrosine phosphatase and tyrosine kinase activity

#21
20180258025
2018-09-13

Labile esters of agrochemicals for controlled release and reduction of off-site movement

#22
20180230111
2018-08-16

Synthesis of tetracyclines and analogues thereof

#23
20180148413
2018-05-31

Substituted pyridines and uses thereof

#24
20180127381
2018-05-10

6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection

#25
20180072761
2018-03-15

Trans-cycloheptenes and hetero-trans-cycloheptenes for bioorthogonal coupling

#26
20180072683
2018-03-15

Pyridazine derivatives as RORc modulators

#27
20180051010
2018-02-22

Pyridazine derivatives as RORc modulators

#28
20170226053
2017-08-10

Sulfonylaminobenzamide compounds as anthelmintics

#29
20170189581
2017-07-06

Click-crosslinked hydrogels and methods of use

#30
20170143840
2017-05-25

Bio-orthogonal drug activation

#31
20170029355
2017-02-02

LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT

#32
20170022216
2017-01-26

Substituted 5-aminothieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4

#33
20160340325
2016-11-24

Synthesis of tetracyclines and analogues thereof

#34
20160226003
2016-08-04

Heterocyclic compounds

#35
20160106859
2016-04-21

Bio-orthogonal drug activation

#36
20150158850
2015-06-11

Graphene nanoribbons with controlled modifications

#37
20150126514
2015-05-07

Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

#38
20150099277
2015-04-09

Tetrazines and method of synthezising the same

#39
20150018309
2015-01-15

Substituted 5-aminothieno[2,3—C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4

#40
20140203215
2014-07-24

Materials for organic electroluminescence devices

#41
20140199331
2014-07-17

Bio-orthogonal drug activation

#42
20140163238
2014-06-12

Synthesis of tetracyclines and analogues thereof

#43
20140142088
2014-05-22

PYRIDAZINONE DERIVATIVES

#44
20140128400
2014-05-08

Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

#45
20140093522
2014-04-03

Bio-orthogonal drug activation

#46
20140031357
2014-01-30

Asymmetrically substituted anthrapyridazone derivatives as cytostatics

#47
20130261299
2013-10-03

Pyridazinyl derivatives as SMO inhibitors

#48
20130217685
2013-08-22

Compounds for modulating RNA binding proteins and uses therefor

#49
20130143874
2013-06-06

Fused ring pyridine compound

#50
20130018051
2013-01-17

Bridged bicyclic heteroaryl substituted triazoles useful as inhibitors

#51
20120289507
2012-11-15

Pyridazinyl derivatives as smo inhibitors

#52
20110288075
2011-11-24

Methods of treating disorders mediated by histamine Hreceptors using pyridazinone derivatives

#53
20110105512
2011-05-05

Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

#54
20110065704
2011-03-17

Compounds for modulating RNA binding proteins and uses therefor

#55
20110009371
2011-01-13

Synthesis of tetracyclines and analogues thereof

#56
20100317665
2010-12-16

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

#57
20100280007
2010-11-04

Pyridazinone derivatives

#58
20100273779
2010-10-28

Aryl pyridazinone derivatives and their use as H3 receptor ligands

#59
20100041663
2010-02-18

Organic Compounds as Smo Inhibitors

#60
20100016545
2010-01-21

Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement

#61
20090128009
2009-05-21

Materials for organic electroluminescence devices

#62
20080261947
2008-10-23

FUSED PYRIDAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT

#63
20080027041
2008-01-31

Pyridizinone derivatives and the use thereof as H3 inhibitors

#64
20070010519
2007-01-11

Pyridazines as 11b-HSD1 inhibitors

#65
20060073472
2006-04-06

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

#66
20050282787
2005-12-22

Synthesis of tetracyclines and analogues thereof

#67
20050085476
2005-04-21

Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient

#68
20050074470
2005-04-07

Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage

#69
20050009830
2005-01-13

Heterocyclic cytotoxic agents